💉National Vaccine Injury Compensation Program Petitions Received
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.
Learn More🚑Funding Extension for Emergency Medical Services for Children
HRSA plans to provide additional funds to the University of Texas at Austin, Texas, the current EIIC Program recipient, to extend the recipient's current period of performance by 12 months. This extension is necessary to support continuity of operations that facilitate pediatric readiness activities in hospital emergency departments (ED) and prehospital emergency medical services (EMS) agencies throughout the country. The current performance period ends June 30, 2025.
Learn More💡NIH Closed Meetings for Grant Application Reviews
The Department of Health and Human Services announces closed meetings of various Integrated Review Groups to evaluate grant applications. These meetings serve as critical opportunities for funding in scientific research across multiple health-related disciplines.
Learn More💻NIH Office of AIDS Research Advisory Council Meeting Notice
The Department of Health and Human Services announces a virtual meeting of the Office of AIDS Research Advisory Council to discuss key reports and strategic plans related to HIV research. The meeting will be accessible to the public, allowing stakeholders to participate and provide input on the agenda items.
Learn More🎓VA National Academic Affiliations Council Meeting Notice
The Department of Veterans Affairs announces a public meeting of the National Academic Affiliations Council, set to discuss partnerships and project updates. The session invites public comments, providing an opportunity for stakeholders to voice opinions on educational matters related to veterans' services, impacting the future direction of collaboration between various entities.
Learn More⚖️DEA Revocation of Khursheed Haider's Registration
The Drug Enforcement Administration (DEA) revoked the registration of Khursheed Haider, M.D. due to his lack of authority to practice medicine in California and handle controlled substances. As a result, business owners in the healthcare sector must remain vigilant about practitioner licensing to avoid regulatory issues.
Learn More💊FDA Draft Guidance on Fluticasone Propionate Impacting Generic Drugs
The Food and Drug Administration (FDA or Agency) is announcing the availability of a new draft guidance for industry entitled "Draft Guidance on Fluticasone Propionate." The new draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for fluticasone propionate nasal spray, metered.
Learn More🏥Correction to Medicare Payment System for Skilled Nursing Facilities
The Department of Health and Human Services announces a correction to the proposed rule on the Medicare payment system for skilled nursing facilities. This correction affects the quality reporting program updates relevant for the federal fiscal year 2026, adjusting a key date within the regulatory timeline for compliance.
Learn More🏥Notice of Meeting - National Research Advisory Council (VA)
The Department of Veterans Affairs announces a public meeting for the National Research Advisory Council (NRAC) on June 4, 2025. The meeting aims to discuss research and policies for veterans' healthcare, including ethics training and agenda planning for the upcoming fiscal year. Public comments will be solicited, allowing stakeholders to voice their opinions.
Learn More💊FDA Revokes Emergency Use Authorizations for Specific Drug Products
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUAs) (the Authorizations) issued to Fresenius Medical Care North America (Fresenius) for multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048), and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). FDA revoked the Authorizations on January 16, 2025, under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocations, including an explanation of the reasons for the revocations, are reprinted in this document.
Learn More